RCRE: Development of Low Carbon Glass-based Architectural Products with Durable Antimicrobial Potential and Beyond (只有英文版本)
研究院/研究中心講座
![20240226 RCRE Seminar](/pair/-/media/department/pair/events/2024/2/20240226-rcre-seminar.png?bc=ffffff&h=540&w=1000&hash=0D3993BA22C741A97689AECA9E6648E3)
-
日期
2024年2月26日
-
主辦單位
Research Centre for Resources Engineering towards Carbon Neutrality (RCRE)
-
時間
17:00 - 18:00
-
地點
Online via Zoom
講者
Dr Chiou Jiachi, Amber
摘要
Abstract
The world has been under constant threat of global warming and emerging/reemerging diseases and Hong Kong is no exception. Hong Kong's Climate Action Plan 2050 was released to reduce total carbon emissions by half against the 2005 level before 2035, achieving carbon neutrality before 2050. On the other hand, Hong Kong as one of the major international cities and a paramount hub connecting Mainland China is filled with international business travellers and tourists, making it a perfect stop for disease transmission. With the multidisciplinary team members from CEE, SFT and FSN, we have developed novel architectural materials with not only the capacity to trap carbon dioxide but also antibacterial/antiviral effect. Two out of the four major decarbonization strategies, namely the green building and waste management, were adopted to prepare the construction materials. A positive-charged polymer with broad-spectrum of antiseptic and disinfectant property was added in the construction mortar. This study showcases the possibilities of integrating architectural and biotech factors to create novel architectural materials beneficial for both environment and human health.
Biography
Dr Jiachi Chiou, Amber, received her Ph.D. with major in Food Science and Molecular Biology from Rutgers University, USA. After joining the Hong Kong Polytechnic University as a Postdoc Fellow, she participated in the projects including pathogenesis and antimicrobial resistance of foodborne pathogens. In the capacity of Pl, Dr Chiou has started the research on studying the effect of gut microbiome on human health with the focus on metabolic diseases and early life nutrition. At the same time, she has actively involved in the development of antibacterial and antiviral materials with colleagues from different disciplines. Since the COVID-19 pandemic, Dr Chiou has engaged in setting up the Molecular Diagnostic Laboratory (MDL) of PolyU, which received HOKLAS accreditation in 2020 and entered Hong Kong government recognized local COVID- 19 testing centres in the same year. She received three Faculty awards on the SARS-CoV 2 relevant works for 3 continuous years in different categories between 2019-2022.
你可能也感興趣